10.1 Cellular Adaptation and Mechanisms of Cell Death

1. Cellular Adaptations to Environmental Stress

Cells maintain a tightly regulated physiological steady state (homeostasis). Excessive physiological stress or pathological stimuli induce reversible adaptive responses to preserve cellular viability:

[!NOTE] Clinical Focus — Drug-Induced Gingival Hyperplasia: Three major pharmaceutical classes induce drug-induced gingival enlargement (overgrowth):

1. Anticonvulsants: Phenytoin (affects ~50% of long-term patients).
2. Calcium Channel Blockers: Nifedipine (affects up to 20–40% of patients), amlodipine.
3. Immunosuppressants: Cyclosporine (affects ~30% of solid organ transplant recipients). All three classes interfere with cellular calcium (Ca²⁺) homeostasis, impairing fibroblast uptake of folic acid and suppressing matrix metalloproteinase production. Fibroblasts synthesize excessive sulfated glycosaminoglycans and collagen, an effect exacerbated by plaque-induced inflammation.

---

2. Mechanisms of Cell Death: Necrosis versus Apoptosis

When stress exceeds cellular adaptive capacity, irreversible injury leads to cell death:

Patterns of Tissue Necrosis

1. Coagulative Necrosis: Default pattern of ischemic tissue necrosis in all solid organs except the brain. Denaturation of structural and enzymatic proteins blocks autolysis, preserving the underlying structural tissue architecture as pale "ghost cells" for several days.
2. Liquefactive Necrosis: Driven by rapid hydrolytic enzymatic digestion of dead cells, transforming the necrotic parenchyma into a viscous liquid mass (pus). Characterises bacterial abscesses where PMNs release destructive lysosomal hydrolases. Dental pulp necrosis following bacterial ingress through deep dentinal caries represents classic liquefactive necrosis, culminating in an acute periapical abscess.
3. Caseous Necrosis: Characteristic of tuberculosis (Mycobacterium tuberculosis). Grossly presents as friable, cheese-like yellowish debris. Histologically demonstrates an amorphous, structureless, granular eosinophilic core surrounded by a granulomatous collar of epithelioid histiocytes, Langhans giant cells, and lymphocytes.
4. Gangrenous Necrosis: Clinical term for ischemic coagulative necrosis of a limb or extremity, which can become complicated by secondary bacterial infection leading to superimposed liquefactive necrosis (wet gangrene). In malnourished children in developing nations, Cancrum Oris (Noma) presents as a devastating, rapidly spreading gangrenous necrosis of the lips, cheeks, and underlying facial bones.

The Apoptotic Pathways: Intrinsic vs Extrinsic

   INTRINSIC (MITOCHONDRIAL) PATHWAY                 EXTRINSIC (DEATH RECEPTOR) PATHWAY
  ┌─────────────────────────────────┐               ┌──────────────────────────────────┐
  │ DNA Damage, Hypoxia, Stress     │               │ FasL / TNF-α binds Death Receptor│
  │ Activation of BH3-only proteins │               │ (Fas / CD95 or TNFR1)            │
  │ (BIM, PUMA, NOXA)               │               │                                  │
  │ BAX / BAK form mitochondrial    │               │ Recruitment of Adaptor (FADD)    │
  │ pores (MOMP)                    │               │                                  │
  │                                 │               │ Cleavage / Activation of         │
  │ Release of CYTOCHROME C         │               │ INITIATOR CASPASE-8              │
  │ Cytochrome c + APAF-1 + dATP    │               └────────────────┬─────────────────┘
  │ ➔ Forms APOPTOSOME              │                                │
  │ Activation of INITIATOR         │                                │ (Cleaves BID to tBID: Crosstalk)
  │ CASPASE-9                       │                                │
  └────────────────┬────────────────┘                                │
                   │                                                 │
                   └───────────────────────┬─────────────────────────┘
                                           │
                                           ▼
                             [EXECUTIONER CASPASES-3 & -7]
                                           │
                                           ▼
                             • Cleave cytoskeletal proteins (actin, lamin)
                             • Cleave ICAD ➔ Activates CAD (CAD nuclease)
                             • Internucleosomal DNA fragmentation (180–200 bp)
                                           │
                                           ▼
                                [APOPTOTIC BODY FORMATION]
                             (Externalised Phosphatidylserine)
                                           │
                                           ▼
                             [Phagocytosis without Inflammation]

• Intrinsic (Mitochondrial) Pathway: Triggered by internal cellular stress, growth factor withdrawal, or DNA damage. Governed by the BCL-2 protein family:
  • Anti-apoptotic: BCL-2, BCL-XL, MCL-1 (preserve outer mitochondrial membrane integrity).
  • Pro-apoptotic effectors: BAX and BAK.
  • BH3-only sensors: BIM, BID, PUMA, NOXA (activated by p53 in response to DNA damage).
  • Upon activation, BAX and BAK oligomerise in the outer mitochondrial membrane, inducing mitochondrial outer membrane permeabilisation (MOMP). This releases Cytochrome c into the cytosol. Cytochrome c binds APAF-1 (apoptotic protease activating factor-1) in the presence of dATP to form the wheel-shaped apoptosome, which recruits and activates initiator Caspase-9.
• Extrinsic (Death Receptor) Pathway: Triggered by engagement of plasma membrane death receptors belonging to the TNFR family (e.g., Fas / CD95, TNFR1). Binding of FasL (expressed on cytotoxic T lymphocytes) to Fas causes receptor trimerisation and recruitment of the adaptor protein FADD (Fas-associated death domain), forming the death-inducing signaling complex (DISC) that activates initiator Caspase-8.
• Execution Phase: Both initiator caspases (9 and 8) converge to cleave and activate downstream executioner caspases (Caspase-3, Caspase-6, Caspase-7). Caspase-3 cleaves the inhibitor of caspase-activated DNase (ICAD), releasing CAD to cleave genomic DNA at internucleosomal linker regions, producing the characteristic 180–200 base pair DNA laddering.

---

Oral Examples of Each Adaptation

General pathology is examined through oral examples, so each adaptive change should be anchored to a lesion you would actually see. Hypertrophy — increased cell size — is seen in the masseter of a bruxist. Hyperplasia — increased cell number — is seen in drug-influenced gingival enlargement with phenytoin, ciclosporin and calcium channel blockers, and in denture-induced fibrous hyperplasia. Atrophy is seen in the epithelium of a patient with iron or B12 deficiency, producing a smooth, depapillated tongue, and in disuse atrophy of alveolar bone after tooth loss. Metaplasia — replacement of one differentiated cell type by another — is seen in the squamous metaplasia of salivary ducts in necrotising sialometaplasia and in smokers' respiratory epithelium. Dysplasia is not an adaptation but a disordered, premalignant change, and the distinction between reversible metaplasia and potentially irreversible dysplasia is a standard examination discrimination.

Why Necrosis and Apoptosis Matter Clinically

The practical difference is inflammation. Necrosis involves membrane failure and the release of cell contents, so it provokes an acute inflammatory response — the mechanism of pulp necrosis leading to periapical periodontitis. Apoptosis is an energy-dependent, regulated dismantling with the cell fragments phagocytosed intact, so it does not provoke inflammation — the mechanism of physiological cell turnover in the oral epithelium and of the deletion of cells with irreparable DNA damage. Loss of apoptotic control through mutation of TP53 is a central step in oral carcinogenesis, which links this section directly to the neoplasia material later in the chapter.